biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Gene Therapies

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Sep 03, 2022 12:15pm

186 Views

Post# 34940077

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Gene Therapies

I think you need to start following gene therapy, pof, years late, but still...

You are a funny man, pof. You have made thousands of posts over dozens of forums with many aliases, been banned by Stockhouse, and here you are, trying to argue stuff that you know very little about.

Go read up on gene therapy, pof. (Isaacson's The Code Breaker, or maybe something more scholarly.)

I know, you have so little time, what with all your responsibilities on so many forums.

The whole effing world is chasing gene therapy solutions. FOLLOW THE MONEY, pof.

jd

<< Previous

Bullboard Posts

Next >>

Debt-free cannabis company set for next stage of growth